| 
  • If you are citizen of an European Union member nation, you may not use this service unless you are at least 16 years old.

  • Work with all your cloud files (Drive, Dropbox, and Slack and Gmail attachments) and documents (Google Docs, Sheets, and Notion) in one place. Try Dokkio (from the makers of PBworks) for free. Now available on the web, Mac, Windows, and as a Chrome extension!

View
 

CILTEP

Page history last edited by Administrator 6 years, 12 months ago

DIYgenomics CILTEP Nootropics Smart Drug Genomics Study

DIYgenomics wiki homepage

  

Title and Genomera Study Page: CILTEP Nootropics Smart Drug Genomics Study

 

Summary: This study investigates whether genetic predisposition may be implicated in the effectiveness of nootropic smart drugs like CILTEP. This study is overseen by the Rikengenesis IRB (Institutional Review Board).

 

Hypothesis: Individuals with polymorphisms in genes related to nootropic targeting and processing may be more likely to benefit from them.

 

Study conduct: The study is conducted in two parts that examine genetic profile and phenotypic response.

 

Genetic Analysis through Personal Genome Files

Function Gene SNP Alleles Note  
 
Citation Link
L-theanine & caffeine CYP1A2 rs762551 C A  
 
 
Cornelis 2006 http://www.ncbi.nlm.nih.gov/pubmed?cmd=Search&term=16522833
L-theanine & caffeine  
 
 
 
 
 
 
 
fast/slow caffeine metabolizer; A fast metab; C slow
long-term potentiation  
 
 
 
 
 
 
 
 
episodic memory performance KIBRA rs17070145 C T T = favorable  
Franks 2014 http://www.ncbi.nlm.nih.gov/pubmed/25339899
episodic memory performance  
 
 
 
 
 
 
 
http://www.snpedia.com/index.php/Rs17070145
GABA, Neuroplastins Np65 and Np55  NPTN rs7171755 A G G = favorable  
Desrivières ‎2014 http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2013197a.html
GABA, Neuroplastins Np65 and Np55   
 
 
 
 
 
 
Beesley 2014 http://www.ncbi.nlm.nih.gov/pubmed/25300133
Bioflavanoid processing CYP1A1 2A  rs4646903 A C  
 
 
Hamachi 2013 http://www.ncbi.nlm.nih.gov/pubmed/23840148
Bioflavanoid processing CYP1A1 2C  rs1048943 A G  
 
 
Hamachi 2013 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677005/
Bioflavanoid processing NQO1 C609T rs1800566 C T  
 
 
Hamachi 2013  
Bioflavanoid processing GSTM1 rs4147565 G A  
 
 
Agúndez JA http://www.ncbi.nlm.nih.gov/pubmed/18303971?dopt=Abstract
 mucopolysaccharidosis GUSB rs9530 C T  
 
 
 
http://www.jci.org/articles/view/72339
 mucopolysaccharidosis  
 
 
 
 
 
 
 
https://www.google.com/search?q=snpedia+gusb; http://en.wikipedia.org/wiki/GUSB
Klotho KL C1548T  no rs # T C  
 
 
Kim 2014 http://www.ncbi.nlm.nih.gov/pubmed/25120167
Klotho KL rs9536314 T G G = favorable in 23 Dubal 2014 http://www.cell.com/cell-reports/fulltext/S2211-1247%2814%2900287-3
Klotho KL rs9527025 G C C = favorable n/a 23 Dubal 2014  
Tyrosine hydroxylase  TH rs10770141 C T T = favorable  
Horiguchi 2014 http://www.ncbi.nlm.nih.gov/pubmed/24417771
Tyrosine hydroxylase   
 
 
 
 
 
 
 
http://circ.ahajournals.org/content/116/9/993.full
UDP-Glucuronosyltransferase UGT rs8330 C G  
 
 
Court 2013 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629801/
bilirubin level influencer UGT1A1 rs887829 A G  
 
 
Chen 2012 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306855/
phenobarbital response enhancer module UGT1A1 rs10929302  G A  
 
 
Chen 2012 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306855/
bioavailability of luteolin  (a flavone, a type of flavonoid)  
 
 
 
 
 
Lin 2008 http://www.ncbi.nlm.nih.gov/pubmed/18991571
beta glucuronidase activity UGT1A3 rs3806596  n/a 23andMe  
 
Santoro 2014 http://onlinelibrary.wiley.com/doi/10.1111/bcp.12437/abstract
 
UGT1A3 rs1983023 n/a 23andMe  
 
 
 
 
UGT1A3 A17G, Q6R;  what rs SNPs?  
 
Chen 2006 http://www.ncbi.nlm.nih.gov/pubmed/16738032
 
UGT1A3 T31C, W11R;  what rs SNPs?  
 
 
flavonoids: quercetin, luteolin, and kaempferol
 
UGT1A3 C133T, R45W; and  what rs SNPs?  
 
 
 
 
UGT1A3 T140C, V47A what rs SNPs?  
 
 
 
Dopamine SNPs COMT Val158met rs4680 A G  
 
 
Mitaki 2013 http://www.ncbi.nlm.nih.gov/pubmed/22530780
Luteolin is a substrate of COMT DR 4 (DRD4) rs1800955 C T  
 
 
He 2012 http://www.nature.com/srep/2012/120920/srep00677/full/srep00677.html
 
DRD2 rs1076560 C A  
 
 
Wang 2013 http://www.ncbi.nlm.nih.gov/pubmed/23421762
 
 
 
 
 
 
 
 
Clarke 2013 http://onlinelibrary.wiley.com/doi/10.1111/ahg.12046/abstract
Renin-angiotensin-aldosterone  
 
 
 
 
 
 
 
 
Aldosterone CYP11B2 rs1799998 A G higher risk for G carriers Jia 2012 http://www.ncbi.nlm.nih.gov/pubmed/22508051?dopt=Abstract
Angiotensin-converting enzyme ACE rs4343 G A  
 
 
 
 
Angiotensin AGTR1 rs5182 A C  
 
 
 
 
Angiotensin AGTR1 rs5182 C T  
 
 
 
Aldosterone synthase (CYP11B2)- 344 C/T polymorphism
Angiotensin AGT rs5049 G A  
 
 
 
 
Angiotensin AGT rs5051 G A  
 
 
 
 
Angiotensin AGT rs699 T C  
 
 
 
 
Angiotensin AGT rs4762 C T  
 
 
 

 

PDE4/Adenylate cyclase PDE4D rs1588265 A G       Apuhan 2013
http://www.ncbi.nlm.nih.gov/pubmed/24142618
PDE4/Adenylate cyclase ADRB2 rs1042713 G A       Eyler 2008; Kim 2011

http://www.ncbi.nlm.nih.gov/pubmed/18324973; http://www.ncbi.nlm.nih.gov/pubmed/21545619

PDE4/Adenylate cyclase ADCY6 rs3730070 G C       Eyler 2008 http://www.ncbi.nlm.nih.gov/pubmed/18324973
PDE4/Adenylate cyclase ADCY6 rs3730071 G A/C       Eyler 2008 http://www.ncbi.nlm.nih.gov/pubmed/18324973
PDE4/Adenylate cyclase ADCY6 rs7300155 G A       Eyler 2008 http://www.ncbi.nlm.nih.gov/pubmed/18324973
PDE4/Adenylate cyclase ADCY9 rs2230739 A G       Kim 2011 http://www.ncbi.nlm.nih.gov/pubmed/21545619

 


 

Comments (0)

You don't have permission to comment on this page.